Moreover, IHC experiments with the tumor tissues revealed that the positive signal of E-cadherin was the strongest in the combination group, while those of N-cadherin and vimentin were the weakest among the four groups, suggesting that combination therapy effectively inhibited EMT formation in tumor tissues in vivo, consequently reversing drug resistance. The gene discussed is CDH2; the disease is neoplasm.